This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Muscle Glycogen Synthesis When Caffeine and Protein is Co-Ingested With Carbohydrates

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Milou Beelen, Maastricht University Medical Center
ClinicalTrials.gov Identifier:
NCT00975390
First received: September 10, 2009
Last updated: April 13, 2015
Last verified: April 2015
  Purpose

The aim of the present study is to investigate the effect of added protein+leucine or caffeine to 1.2 g/kg/h CHO on the rate of post-exercise muscle glycogen re-synthesis in healthy, recreational athletes.

The investigators hypothesize that both interventions (the addition of caffeine or protein+leucine) will lead to higher glycogen re-synthesis compared to the ingestion of CHO only, and that the co-ingestion of protein and leucine will result in the highest muscle glycogen synthesis rates.


Condition Intervention
Exercise Recovery Dietary Supplement: Carbohydrate Dietary Supplement: Carbohydrate and protein ingestion Dietary Supplement: Carbohydrate and caffeine ingestion

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double Blind (Participant, Investigator)
Primary Purpose: Basic Science
Official Title: The Effect of Caffeine or Protein Co-ingestion With Carbohydrate on Post-exercise Muscle Glycogen Synthesis Rate.

Resource links provided by NLM:


Further study details as provided by Milou Beelen, Maastricht University Medical Center:

Primary Outcome Measures:
  • Muscle glycogen synthesis rates [ Time Frame: 6 hours ]

Secondary Outcome Measures:
  • Glycogen synthase activity, plasma glucose, insulin, free fatty acids and epinephrine responses [ Time Frame: 6 hours ]

Enrollment: 14
Study Start Date: February 2009
Study Completion Date: September 2009
Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Carbohydrate ingestion
Dietary Supplement: Carbohydrate
1.2 g/kg/h
Experimental: 2
Carbohydrate and protein ingestion
Dietary Supplement: Carbohydrate and protein ingestion
1.2 g/kg/h carbohydrate plus 0.4 g/kg/h protein
Experimental: 3
Carbohydrate and caffeine ingestion
Dietary Supplement: Carbohydrate and caffeine ingestion
1.2 g/kg/h carbohydrate and 1.67 g/kg/h caffeine

  Eligibility

Ages Eligible for Study:   18 Years to 35 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • male cyclists
  • healthy
  • BMI < 25

Exclusion Criteria:

  • female
  • use of medication
  • non cycling
  • BMI > 25
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00975390

Locations
Netherlands
Maastricht University
Maastricht, Netherlands
Sponsors and Collaborators
Maastricht University Medical Center
  More Information

Responsible Party: Milou Beelen, Dr., Maastricht University Medical Center
ClinicalTrials.gov Identifier: NCT00975390     History of Changes
Other Study ID Numbers: 08-3-066
Study First Received: September 10, 2009
Last Updated: April 13, 2015

Keywords provided by Milou Beelen, Maastricht University Medical Center:
Glycogen
Carbohydrate
Protein
Caffeine
Post exercise muscle glycogen synthesis
Sports nutrition

Additional relevant MeSH terms:
Caffeine
Central Nervous System Stimulants
Physiological Effects of Drugs
Phosphodiesterase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Purinergic P1 Receptor Antagonists
Purinergic Antagonists
Purinergic Agents
Neurotransmitter Agents

ClinicalTrials.gov processed this record on July 21, 2017